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TABLE I. OUTCOME OF THE PREGNANCIES IN THE 15
PATIENTS TREATED
RESULTS
early (first trimester) abortions, and 5 presenting with
threatened abortion at 6 - 8 weeks' gestation.
As far as was practicable, all known possible causes for
abortion were excluded. All 15 patients were clinically
normal and healthy, and had negative serology tests for
syphilis, negative toxoplasmosis complement fixation tests,
and normal routine urinalysis, blood counts and bio-
chemistry.
Lateral vaginal smears were cytologically examined to
determine the degree of progesterone deficiency. The
smears were classified good, fair and poor, according
to the classification of Burton and Wachtel.' However, a
finding of a karyopyknotic index of greater than 10% in
the current pregnancy was the single most important factor
in selecting patients with a previous history of early
abortion for therapy with HCG.
All 15 patients had poor initial smears and were given
HCG (Pregnyl; Organon) 5 000 ill by deep intramuscular
injection twice weekly from the time of diagnosis (all
before the 7th week of gestation, except for 1 case of
threatened abortion presenting at 8 weeks) until the 16th
week. If uterine growth failed to correlate with the dura-
tion of gestation, an ultrasonogram was taken at the 12th
week. This was done on 4 occasions. No other drugs or
vitamin supplements were administered. 0 advice in
relation to bedrest, etc. was given.
The outcome of the IS pregnancies is shown in Table I.
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PATIENTS AND METHODS
SUMMARY
Progesterone insufficiency is recognised as a cause of re-
productive failure, albeit very rare. The replacement of
one ovarian steroid in such cases does not appear to be
entirely physiological, but the replacement of a spectrum
of steroids is not as yet practical. It was therefore con-
sidered that the administration of human chorionic gona-
dotrophin itself would produce better corpus luteum
stimulation, on theoretical grounds at least, and result
indirectly in better trophoblastic stimulation. In this way
it was hoped to salvage cases of threatened abortion due
to progesterone insufficiency. This article is a preliminary
evaluation of early experience obtained with the use of
human chorionic gonadotrophin (HCG) in cases of cyto-
logically demonstrated progesterone deficiency associated
with a history of (a) threatened abortion, and (b) two or
more recurrent abortions.
Vaginal cytology was chosen as a method of assessment
in this study, not only for reasons of simplicity and rapidity
of diagnosis, but because this method has been shown
to be at least as good as hormonal assay.'"
Early experience with the use of human chorionic gona-
dotrophin replacement therapy in a small number of
progesterone-deficient pregnancies is presented. Twelve
out of 15 pregnancies proceeded normally to term and 3
pregnancies were lost. The latter group was associated
with blighted ova and a significant amount of trophoblastic
tissue. The findings in this small preliminary trial appear
to justify a broader controlled investigation into the value
of HCG therapy in prevention of threatened or recurrent
abortion associated with progesterone insufficiency.
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The first patient was treated in 1967. Since then, with
strict selection, 15 patients have been treated during early
pregnancy, 10 having a previous history of two or more
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Three of the 5 patients presenting with threatened
abortion settled clinically, and the pregnancies continued
successfully to term. In 2 patients the uterus failed to
enlarge according to dates. An ultrasonogram in the one
instance revealed a large pregnancy sac, but without evi-
dence of a fetus. This patient underwent evacuation of
the uterus under anaesthesia. The other patient aborted
spontaneously. Examination of the products of conception
confirmed the presence of blighted ova in both instances.
A significant finding was the marked degree of tropho-
blastic development in relation to the pregnancy sacs, a
finding which was expected in the first case from the
appearance of the sac on the ultrasonogram. One patient
continued to bleed for 2 weeks, but uterine growth con-
tinued and ultrasonography confirmed the presence of a
normal fetus (see case 1).
Nine of the 10 patients presenting with poor vaginal
smears and a previous history of early abortion proceeded
successfully to term. One patient was suspected of having
a twin pregnancy; an ultrasonogram revealed a single fetus
and confirmed the duration of gestation. Uterine growth
failed to keep pace with dates in I patient; ultrasono-
graphy confirmed the presence of a suspected blighted
ovum (see case 2), and after uterine evacuation the signi-
ficant finding once again was the marked degree of tropho-
blastic tissue present in relation to the size of the sac
enclosing the blighted ovum.
Except for the 3 pregnancies lost because of blighted
ova, the remaining 12 pregnancies proceeded to term with-
out complication. All 12 infants were normal and healthy.
No congenital abnormalities were found in this series.
No abnormal drug effects were noted and no patients




This 22-year-old patient presented at 6 weeks' gestation
with a history of 2 previous abortions at 7 - 8 weeks'
gestation. Previous investigation for a cause of repro-
<Iuctive failure had been negative. Vaginal smears for
cytology were taken, but before assessment the patient
commenced vaginal bleeding, confirmed to be uterine in
<>rigin and unassociated with uterine contractions. She
was immediately hospitalised, although no active therapy
was commenced for 48 hours. Thereafter the original
vaginal smear was reported as showing a poor progesterone
effect, and the pregnancy test was positive. HCG therapy
was commenced, and bleeding ceased at 96 hours. There
were no further complications during the pregnancy. At
12 weeks' gestation an ultrasonogram confirmed the pre-
sence of a high fundal insertion of a normal-looking preg-
nancy of about 12 weeks' duration, with the head just
visible. HCG therapy was stopped at 16 weeks' gestation,
and the patient was subsequently. delivered of a live, nor-
mal and healthy infant at term. without further complica-
tion.
Case 2
This patient, aged 39 years. presented initially for
investigation of reproductive failure. She had a previous
history of 3 pregnancies, all resulting in spontaneous
abortion at 8 weeks' gestation. 0 cause had been found.
Routine investigations (thyroid function, glucose tolerance
test, toxoplasmosis complement fixation test, serology for
syphilis, etc.) were all negative. Shortly after investigation
commenced the patient conceived spontaneously. Vaginal
cytology at 6 weeks' gestation revealed a poor progesterone
effect. It was decided to attempt HCG therapy and this
was started from 6 weeks' gestation in the usual dosage of
5000 IV by intramuscular injection twice weekly. At 12
weeks' gestation it was noted that the uterine size did not
conform to dates, and during the next 2 weeks this lag
became more marked. There was, however, no evidence of
threatened abortion. At 14 weeks' gestation an ultrasono-
gram was taken, and this showed the presence of an
empty gestational sac, but associated with profuse tropho-
blastic tissue. Uterine evacuation was undertaken by
vacuum aspiration, and the gestational sac obtained in fOto.
Examination of the sac confirmed the presence of a
blighted ovum. and excessive surrounding placental tissue.
DISCUSSION
This presentation is considered to be no more than an
evaluation of early experience with the use of HCG
therapy in the presence of threatened or recurrent abor-
tion. The number of cases is small, and the results
average. However, the type of case being treated, the
high incidence of blighted ova in the failed cases, and the
excessive amount of trophoblastic tissue present in the
abortuses, do appear to justify such therapy on more
than theoretical grounds, and to warrant a broader con-
trolled investigation in a greater number of cases.
In considering the role of HCG it is, in fact, paradoxical
that so large a body of knowledge could accumulate on
the pharmacology and chemistry of a hormone with so
little being known about its physiological action. Although
the pharmacological action of HCG in unphysiological use
in different animal species is relatively well understood, its
physiological actions on the mother, on the fetus and on
the placenta are still obscure!
The history of HCG therapy in threatened abortion is
of interest. Brown and Bradbury; in a classic paper pub-
lished in 1947, evaluated the effect of HCG therapy in
normal women. Prior to their use of purified HCG, pre-
vious commercial preparations had been too bulky and
had caused severe reactions. They showed HCG to pro-
duce persistence of the corpus luteum, decidual changes
in the endometrium, prolonged excretion of pregnanediol,
and positive Aschheim-Zondek tests on the urine. Although
they suggested the use of HCG in threatened or habitual
abortion they did not describe any cases with such treat-
ment. Their work was confirmed by Fried and Rakoff' in
1952. The first clinical report of HCG therapy in adequate
dosage appears to be that of Holund' in 1953, although
duration of therapy was short. HCG 6000 IU was given
daily for 5 days to 47 cases of threatened abortion. Fetal
salvage was achieved in 72% of the patients; nevertheless,
Holund was sceptical about the value of such therapy and
felt that equally good results could have been obtained
with non-specific therapy.
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There have been several other reports of HCG therap'y,
alone or in various combinations with oestrogen and
progesterone.'" Nevertheless, there still appear to be no
adequately controlled studies of HCG therapy alone and in
adequate dosage.
Hughes et al.' have stated that the information pro-
vided by vaginal cytology in predicting the eventual out-
come of pregnancy in patients with threatened abortion is
superior to that obtained by hormonal analyses, such as
urinary oestrogen, pregnanediol and HCG assays. Although
these findings have been questioned by Brown et al.,"
vaginal cytology was used as a means of assessment in the
present study. Following HCG therapy, vaginal smears
were found to revert from higWy oestrogenised to well-
progestinised in several individual cases. The significance
of these findings, however, will have to be tested in a
larger series of cases. Nevertheless, this finding is also
considered to lend some support to the use of HCG thera-
py at the present time. .
The finding of major interest was the large amount of
trophoblastic development present in cases ultimately abort-
ing. This would add credence to the theory that the tro-
phoblast is being well stimulated through corpus luteum
support with HCG therapy. This finding alone appears to
warrant the use of HCG supportive therapy in pro-
gesterone-insufficient pregnancies, and to justify further
evaluation of this fonn of treatment in larger controlled
studies.
That 3 of the pregnancies resulted in blighted ova was
expected on a statistical basis. l1,,, The fact that chromo-
some anomalies account for a significant fetal wa tage
in cases of threatened and recurrent abortion"'" does not
imply that an entirely pessimistic attitude is in order. or
do findings such as those of Sheannan and Garrett,13 who
reported as good results with placebo therapy as with pro-
gesterone replacement in 50 habitual abortion patients.
entirely exclude the possibility of hormone deficiency
states being aetiological factors in abortion. Such work
has, however, resulted in a rather negative approach to
endocrine aspects of abortion in current research. lever-
theless, further controlled investigations are still required.
and it is hoped that the rationale behind HCG therapy
will be further elucidated.
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